This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Acquired decrease of the C3b/C4b Receptor (CR1, CD35) and C4d deposits on Erythrocytes from ICU COVID-19 Patients (preprint)
medrxiv; 2020.
Preprint
in English
| medRxiv | ID: ppzbmed-10.1101.2020.08.10.20162412
ABSTRACT
We determined CR1, CD35 the C3b, C4b receptor density, C3b/C3bi and C4d deposits densities on Erythrocytes (E) in 51 COVID-19 patients undergoing O2 therapy or assisted ventilation in ICU units in Rheims France. A clear acquired decrease of CR1 density of E from COVID-19 patients was observed, particularly among fatal cases, and paralleling several severity parameters. Deposits of C4d largely above values observed in normal individuals, mostly without C3 deposits, have been observed in more than 80% of the patients, reminiscent of the sub endothelial pericapillary deposits in organ transplant rejection, already observed on E in parallel, as well as also observed on E in clinical SLE flares. Conversely, significant C3 deposits were only observed among [1/4] of the patients. The decrease of CR1/E density, and the detection of virus spike, C3 or C4 fragment on E, among COVID-19 patients, are likely to be two aspects of the same phenomenon of immune complexes or complement fragment coated cell debris handling and clearance. Measurement of C4d deposit on E might represent a way for assessing inflammation and complement activation occurring in organ capillaries. CR1/E decrease might represent a cumulative index of complement activation in COVID-19 patients. Taken together, these original findings stress on the participation of the complement regulatory proteins in that disease and evidence that E matter in immune mechanisms in COVID-19 patients. The use of CR1, or CR1-like molecules with the aim of down regulating complement activation and inflammation for therapy should also be considered. HIGHLIGHTSO_LIAcquired decrease of CR1 on E in COVID-19 patients, particularly among fatal cases, and paralleling several severity parameters. C_LIO_LILarge C4d deposits on E in most patients, reminiscent of the pericapillary deposits in organ transplant rejection, already observed on E in parallel, as well as on E from SLE flares. C_LIO_LIC4d deposit on E, a possible way for assessing inflammation and complement activation in organ capillaries. C_LIO_LIDecreased CR1/E, a possible cumulative index of complement activation in COVID-19 patients. C_LIO_LIThe use of CR1 or CR1-like molecules for down regulating complement activation for therapy should also be considered. C_LI
Full text:
Available
Collection:
Preprints
Database:
medRxiv
Main subject:
COVID-19
Language:
English
Year:
2020
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS